These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 16712958)
1. Myelin flow cytometry assay detects enhanced levels of antibodies to human whole myelin in a subpopulation of multiple sclerosis patients. Breij EC; Heijnen P; van der Goes A; Teunissen CE; Polman CH; Dijkstra CD J Neuroimmunol; 2006 Jul; 176(1-2):106-14. PubMed ID: 16712958 [TBL] [Abstract][Full Text] [Related]
2. Serum antibodies to conformational and linear epitopes of myelin oligodendrocyte glycoprotein are not elevated in the preclinical phase of multiple sclerosis. Chan A; Decard BF; Franke C; Grummel V; Zhou D; Schottstedt V; Toyka KV; Hemmer B; Gold R Mult Scler; 2010 Oct; 16(10):1189-92. PubMed ID: 20685767 [TBL] [Abstract][Full Text] [Related]
3. Studies on anti-myelin antibodies in patients with multiple sclerosis. Nobile-Orazio E; Spagnol G; Daverio R; Riboni L; Macchi R; Francomano E; Scarlato G Riv Neurol; 1987; 57(1):13-9. PubMed ID: 3629125 [TBL] [Abstract][Full Text] [Related]
4. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. Lalive PH; Menge T; Delarasse C; Della Gaspera B; Pham-Dinh D; Villoslada P; von Büdingen HC; Genain CP Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2280-5. PubMed ID: 16461459 [TBL] [Abstract][Full Text] [Related]
5. Recombinant forms of myelin antigens expressed on Chinese hamster ovary (CHO) cells as a tool for identification of autoantibodies in serum of multiple sclerosis patients. Jaśkiewicz E; Michałowska-Wender G; Pyszczek A; Wender M Folia Neuropathol; 2010; 48(1):45-8. PubMed ID: 20383810 [TBL] [Abstract][Full Text] [Related]
6. Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments. Khalil M; Reindl M; Lutterotti A; Kuenz B; Ehling R; Gneiss C; Lackner P; Deisenhammer F; Berger T J Neuroimmunol; 2006 May; 174(1-2):147-56. PubMed ID: 16516980 [TBL] [Abstract][Full Text] [Related]
7. Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study. Lily O; Palace J; Vincent A Brain; 2004 Feb; 127(Pt 2):269-79. PubMed ID: 14662514 [TBL] [Abstract][Full Text] [Related]
8. Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults. Wang H; Munger KL; Reindl M; O'Reilly EJ; Levin LI; Berger T; Ascherio A Neurology; 2008 Oct; 71(15):1142-6. PubMed ID: 18753473 [TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid anti-whole myelin antibodies are not correlated to magnetic resonance imaging activity in multiple sclerosis. Tewarie P; Teunissen CE; Dijkstra CD; Heijnen DA; Vogt M; Balk L; Vrenken H; Polman CH; Killestein J J Neuroimmunol; 2012 Oct; 251(1-2):103-6. PubMed ID: 22858371 [TBL] [Abstract][Full Text] [Related]
10. Serum antibodies to 25 myelin oligodendrocyte glycoprotein epitopes in multiple sclerosis and neuromyelitis optica: clinical value for diagnosis and disease activity. Xu Y; Zhang Y; Liu CY; Peng B; Wang JM; Zhang XJ; Li HF; Cui LY Chin Med J (Engl); 2012 Sep; 125(18):3207-10. PubMed ID: 22964310 [TBL] [Abstract][Full Text] [Related]
11. Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis. Olsson T; Baig S; Höjeberg B; Link H Ann Neurol; 1990 Feb; 27(2):132-6. PubMed ID: 1690527 [TBL] [Abstract][Full Text] [Related]